NTRA 161.88 (+2.4%)
US6323071042Medical Diagnostics & ResearchDiagnostics & Research

Natera (NTRA) Stock Highlights

161.88 | +2.4%
2024-12-21 00:43:27
Natera Inc is operative in the healthcare field in the United States. Its core business is to offer invasive and other means of diagnosing the genetic features of a fetus. Nateras array of diagnostic services includes Panorama Non-Invasive Prenatal Test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, Anora Products of Conception (POC) test to analyze fetal chromosomes to understand the cause of miscarriage, and Non-Invasive Paternity Testing (PAT), to determine paternity by studying the fragments of fetal deoxyribonucleic acid (DNA) in a pregnant mothers blood and a blood sample from the alleged father. The Company acquires its revenue by billing an insurance carrier, a clinic, or a patient for the test upon delivery of the test result.

Statistics

Range Today
154.01 163.05
Volume Today 2.76M
Range 1 Year
57.22 175.63
Volume 1 Year 334.28M
Range 3 Year
26.1 175.63
Volume 3 Year 1.07B
Range 10 Year
6.52 175.63
Volume 10 Year 1.92B

Highlights

Market Capitalization 16.59B (large)
Floating Shares 119.14M
Current Price 161.88
Price To Earnings -53.9
Price To Revenue 11.52
Price To Book 19.78
Earnings Per Share -2.44
Payout Ratio 0%

Performance

Latest +2.4%
1 Month -1.19%
3 Months +27.98%
6 Months +49.9%
1 Year +174.37%
3 Years +72.23%
5 Years +343.02%
10 Years +799.33%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.